Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2025

Accrued Expenses [Abstract]

Accrued Expenses

Accrued expenses included the following:

		September 30,	December 31,
		2025	2024
Incentive and other compensation costs	$	263,689	650,768
Clinical trial costs		335,224	354,762
Accrued interest		350,338	44,525
Director fees		71,250	70,000
Other		7,960	30,994
Accrued expenses	$	1,028,461	1,151,049